Sale!

LMNA Gene Cardiomyopathy dilated with hypergonadotropic hypogonadism Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The LMNA Gene Cardiomyopathy Dilated with Hypergonadotropic Hypogonadism Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. This test, priced at 4400 AED, is designed to identify mutations in the LMNA gene, which have been associated with a unique form of cardiomyopathy accompanied by hypergonadotropic hypogonadism. Dilated cardiomyopathy (DCM) is a condition characterized by the enlargement and weakening of the heart’s ventricles, which can lead to heart failure and arrhythmias. Hypergonadotropic hypogonadism is a condition where the gonads produce insufficient sex hormones, leading to delayed or absent puberty and reproductive issues, due to a lack of response despite high levels of stimulating hormones.

The LMNA gene encodes lamin A and C, types of nuclear envelope proteins that provide structural support and play a role in gene regulation. Mutations in this gene can disrupt these functions, leading to a variety of diseases, including the specific type of cardiomyopathy associated with hypergonadotropic hypogonadism.

By undergoing this genetic test, individuals suspected of having this condition or those with a family history of similar symptoms can gain valuable insights into their genetic makeup. The results can guide healthcare professionals in developing a personalized treatment plan that addresses both the cardiac and hormonal aspects of the condition. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, this test represents a crucial step towards accurate diagnosis and management of this complex condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

LMNA Gene Cardiomyopathy Dilated with Hypergonadotropic Hypogonadism Genetic Test

Genetic testing plays a crucial role in diagnosing and managing various genetic disorders. One such disorder is LMNA Gene Cardiomyopathy Dilated with Hypergonadotropic Hypogonadism. This genetic disorder affects both the heart and reproductive system and is caused by mutations in the LMNA gene.

Test Details

The LMNA Gene Cardiomyopathy Dilated with Hypergonadotropic Hypogonadism Genetic Test is available at DNA Labs UAE. The test costs AED 4400.0 and can be conducted using a blood sample, extracted DNA, or one drop of blood on an FTA card. The report delivery time is approximately 3 to 4 weeks, and the method used for testing is NGS Technology.

Symptoms and Diagnosis

Individuals with LMNA Gene Cardiomyopathy Dilated with Hypergonadotropic Hypogonadism typically develop dilated cardiomyopathy, which is characterized by the enlargement and weakening of the heart muscle. Common symptoms include fatigue, shortness of breath, and heart palpitations. Additionally, affected individuals may experience hypergonadotropic hypogonadism, a condition where the reproductive system does not produce enough sex hormones.

To diagnose this genetic disorder, a genetic counseling session is recommended. This session helps in drawing a pedigree chart of family members affected by LMNA Gene Cardiomyopathy Dilated with Hypergonadotropic Hypogonadism. The test itself involves NGS genetic testing, which includes sequencing the DNA of an individual to identify any mutations or changes in the LMNA gene.

Importance of Genetic Testing

NGS genetic testing allows healthcare professionals to provide a more accurate diagnosis and develop appropriate treatment plans for affected individuals. By identifying the genetic changes associated with LMNA Gene Cardiomyopathy Dilated with Hypergonadotropic Hypogonadism, healthcare professionals can offer personalized care and management options.

It is important to note that this genetic disorder is rare and can vary in symptoms and severity among affected individuals. Therefore, consulting with a healthcare professional or genetic counselor is crucial for a comprehensive evaluation and guidance on testing and management options.

Conclusion

LMNA Gene Cardiomyopathy Dilated with Hypergonadotropic Hypogonadism is a genetic disorder that affects the heart and reproductive system. Genetic testing, such as the LMNA Gene Cardiomyopathy Dilated with Hypergonadotropic Hypogonadism Genetic Test offered by DNA Labs UAE, plays a vital role in diagnosing and managing this condition. By identifying genetic changes, healthcare professionals can provide personalized care and treatment plans for affected individuals.

Test Name LMNA Gene Cardiomyopathy dilated with hypergonadotropic hypogonadism Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for LMNA Gene Cardiomyopathy, dilated with hypergonadotropic hypogonadism NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with LMNA Gene Cardiomyopathy, dilated with hypergonadotropic hypogonadism NGS Genetic DNA Test gene LMNA
Test Details

LMNA gene cardiomyopathy, dilated with hypergonadotropic hypogonadism is a genetic disorder that affects the heart and reproductive system. It is caused by mutations in the LMNA gene, which provides instructions for producing a protein called lamin A/C. This protein is involved in maintaining the structure and function of the cell nucleus.

Individuals with this condition typically develop dilated cardiomyopathy, which is characterized by the enlargement and weakening of the heart muscle. This can lead to symptoms such as fatigue, shortness of breath, and heart palpitations. Additionally, affected individuals may experience hypergonadotropic hypogonadism, which is a condition where the reproductive system does not produce enough sex hormones.

NGS (Next-Generation Sequencing) genetic testing can be used to diagnose LMNA gene cardiomyopathy, dilated with hypergonadotropic hypogonadism. This type of testing involves sequencing the DNA of an individual to identify any mutations or changes in the LMNA gene that may be causing the condition. By identifying these genetic changes, healthcare professionals can provide a more accurate diagnosis and develop appropriate treatment plans for affected individuals.

It is important to note that this genetic disorder is rare and can have variable symptoms and severity among affected individuals. Therefore, it is crucial to consult with a healthcare professional or genetic counselor for a comprehensive evaluation and guidance on testing and management options.